Total buying$00 buys
LFVN
Lifevantage Corp
NasdaqHealthcarePHARMACEUTICAL PREPARATIONS
Insider activity for last month from 10/02 to 11/02.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$00 sells
Net open-market+$0Buying minus selling
Active insiders3Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Oct 09, 2026
Open-market transaction mix · 0 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Oct 2026 | 0 | 0 | 6 | $0 | $0 | $0 |
| Nov 2026 | 0 | 0 | 0 | $0 | $0 | $0 |
Distinct insiders active
Reporting-owner CIKs by month · peak Oct 2026 (3)Oct 2026Nov 2026
Largest insider activity
By absolute net disclosed value · current transaction page- CK+$0
- AC+$0
- MT+$0
LFVN transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
LFVNLifevantage Corp | Cunningham KristenCSO | A · grantDerivative securitySEC filing ↗ | $0View disclosure → | |
LFVNLifevantage Corp | Cunningham KristenCSO | A · grantSEC filing ↗ | $0View disclosure → | |
LFVNLifevantage Corp | Aure CarlCFO | A · grantDerivative securitySEC filing ↗ | $0View disclosure → | |
LFVNLifevantage Corp | Aure CarlCFO | A · grantSEC filing ↗ | $0View disclosure → | |
LFVNLifevantage Corp | Moorehead TerrencePRES | A · grantDerivative securitySEC filing ↗ | $0View disclosure → | |
LFVNLifevantage Corp | Moorehead TerrencePRES | A · grantSEC filing ↗ | $0View disclosure → |
Filing-only signals
Deterministic matches in the selected period
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period6transactionstxns
- A · Grants / awards · dominant6 · 100%
Activity by reported role
A joint filing can contribute to multiple rolesChief financial officer2
CSO2
PRES2
Reported Holdings After
Separated by insider, security, and ownership type
Moorehead TerrenceCommon Stock · Direct
501,879Oct 07, 2026
Moorehead TerrencePerformance Restricted Stock Units · Direct
289,855Oct 07, 2026
Aure CarlCommon Stock · Direct
191,784Oct 07, 2026
Aure CarlPerformance Restricted Stock Units · Direct
53,623Oct 07, 2026
Cunningham KristenCommon Stock · Direct
152,375Oct 07, 2026
Cunningham KristenPerformance Restricted Stock Units · Direct
49,275Oct 07, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redOct 02 → Nov 02
LessMore
Lifevantage Corp Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Lifevantage Corp?
Cunningham Kristen, Aure Carl, Moorehead Terrence.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
No code-P purchases or code-S sales were reported in the selected period.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.